Diane Von Ah
PhD, RN, FAAN
Mildred E. Newton Endowed Professor Distinguished Professor of Cancer Research
Director of Cancer Research
Biography
Dr. Diane Von Ah is a leader in oncology symptom science and has dedicated her career to improving the lives of cancer survivors and developing the next generation of scientists. Dr. Von Ah’s program of bio-behavioral research has focused on (1) identifying the incidence of subjective and objective cognitive dysfunction, (2) examining the underlying mechanisms of cognitive dysfunction, (3) exploring the impact of cognitive dysfunction on functional limitations, work ability and quality of life, and (4) discovering efficacious interventions to alleviate this potentially debilitating symptom in cancer survivors. Dr. Von Ah’s randomized clinical trials represent the first to fully test the effects of cognitive training to improve cognitive dysfunction in breast cancer survivors and is featured on the National Cancer Institute’s Research Tested Intervention Program website. Her research has been well-funded and disseminated widely appearing in top national and international journals.
Dr. Von Ah has used her expertise in symptom science to mentor the next generation of scientists and serve in leadership positions to support and communicate advancements in the field. She has served on study sections for the NIH and Chaired the Oncology Nursing Society (ONS) Grant Review Program. She was the leader of the ONS’s Putting Evidence into Practice, Cognitive Dysfunction Team and the primary author of the Society’s Research Agenda for 2019-2022. She is an invited Advisory Board Member on the NIH/NCI – Physician Data Query (PDQ ®) Supportive and Palliative Care Board, an interdisciplinary board of clinician scholars who write and disseminate the latest information on cancer symptoms and symptom management for clinicians to utilize in their practice. Most recently, she served on the National Academies of Science, Engineering, and Medicine Committee on Diagnosing and Treating Adult Cancers to review the latest cancer treatment and their effects, specifically identifying the ramifications of cognitive dysfunction on disability in cancer survivors. She has received numerous awards and distinctions in the field of oncology nursing and is a fellow of the American Academy of Nursing.
Dr. Von Ah earned her bachelor’s in Nursing and Master’s of Nursing from the University of Iowa and her PhD from the University of Alabama in Birmingham (UAB). She was a R25 pre-doctoral fellow in Cancer Prevention and Control at UAB where she completed a Susan G. Komen funded dissertation regarding the impact of stress and social support on symptom and immune outcomes in breast cancer survivors. She completed a T32 post-doctoral fellowship at Indiana University School of Nursing in behavioral oncology. As a post-doctoral fellow, she was funded by the Oncology Nursing Foundation to explore underlying mechanisms of cancer and cancer-related impairment and genetics of symptom management in cancer survivors. She was a Robert Wood Johnson Foundation Nurse Faculty Scholar from 2008-2011.
View my publications:
- Von Ah, D.M., Duijts, S. van Muijen, P. de Boer, A. & Munir, F. (2018). Work in Cancer, In Handbook of Cancer Survivorship, Second Edition, Edited by Michael Feuerstein and Larissa Nekhyudov.
- Loughan, A.R., Allen, D. H., & Von Ah, D (2018). Neuropsychological of Chemotherapy in Brain Tumor Patients. In Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, Second Edition. Newton H. (Ed). Elsevier.
- Jansen, C.E., Allen, D.H., Von Ah, D.M., & Johnson, L.A. (2014). Cognitive Impairment in M. Irwin & L.A. Johnson (Eds.), Putting evidence into practice: A pocket guide to cancer symptom management (pp. 59-65) Pittsburgh, PA: Oncology Nursing Society.
- Allen, D., Von Ah, D., Jansen, C., Behrendt, R., Wulff, J., & Schiavone, R.M. (2011) Cognitive impairment. What interventions are effective in managing cognitive impairment in people with cancer? In L. Eaton, J. Tipton & M. Irwin (Eds.) Putting Evidence
- 2023 Connie Henke Yarbro Oncology Research Endowed Guest Lectureship, University of Missouri, Columbia
- 2023 Research Publication Award, Symptom Science RIIG, Midwest Nursing Research Society
- 2021 Distinguished Researcher Award, Symptom Science, Midwest Nursing Research Society
- 2021 Visionary Leader Award, University of Alabama at Birmingham 70th Alumni Celebration
- 2021 First Place Abstract & Poster Award in Symptom Science, NINR-Oncology Nursing Society-NCI Symptom Science Colloquium
- 2019 Best in Research Abstracts Award, 44th Annual Congress in Cancer Nursing, Oncology Nursing Society
- 2019 Daisy Award for Extraordinary Nursing Faculty, Excellence in Mentoring
- 2017 Dean’s Faculty Award for Innovation, Indiana University School of Nursing
- 2017 Best in Research Abstracts Award, 42nd Annual Congress in Cancer Nursing, Oncology Nursing Society
- 2015 Prestigious External Awards Recognition (PEAR) Award, Indiana University Purdue University Indianapolis
- 2014 Rebecca T. Markel Excellence in Mentoring Award, Sigma Theta Tau International Honor Society of Nursing, Alpha Chapter
- 2014 Fellow of American Academy of Nursing
- 2013 Trish Greene - Memorial Quality of Life Lectureship Award, Oncology Nursing Society
- 2012 Excellence in Research Award, Sigma Theta Tau International, Alpha Chapter
- 2011 Mary and John Barron Quality of Life Research Award, Indiana University School of Nursing
- 2009 Victoria Mock New Investigator Award, Oncology Nursing Society
- 2008 New Investigator Award, Midwest Nursing Research Society Women’s Health Section
- 2008 Robert Wood Johnson Foundation Nurse Faculty Scholar 2008-2011
- Program Co-Leader Cancer Control Program: OSU Comprehensive Cancer Center Support Grant, (PI: Pollock, 7.5% effort) National Institutes of Health, NCI P30CA016058-48 $28,664,940 01/2020-11/2025, starting 7/1/2023
- Core Training Faculty: Training in the Science of Health Development, PI Pickler/Happ (unfunded effort) National Institutes of Health/National Institute of Nursing Research T32NR014225 $210,034 08/01/22-06/30/2025
- Contact MPI: Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial, MPIs: Ganz & McDonald (40% effort) National Institutes of Health, National Cancer Institute R01-10562299 $2,766,520 02/01/2023-01/31/2028
- PI: Social determinants and neighborhood analysis of symptom profiles after cancer (5% effort) National Institutes of Health, National Institute of Nursing Research $34,999 7/22/2022-10/19/2024
- PI: Genetic correlates of cognitive dysfunction and its co-occurring symptoms (unfunded effort) National Institutes of Health, National Institute of Nursing Research 24,999+ buccal swabs & Genetic Analysis 11/01/2020-10/31/2021
- Project Scientist: Bio-behavioral correlates of cognitive dysfunction in cancer survivors, Precision Health Initiative PI: Shekhar (50% effort) CTSI & Indiana University Grand Challenge - Precision Health Initiative $541,413 07/01/2019-10/31/2021
- Program Co-Leader Cancer Control Program: OSU Comprehensive Cancer Center Support Grant, (PI: Pollock, 7.5% effort) National Institutes of Health, NCI P30CA016058-48 $28,664,940 01/2020-11/2025, starting 7/1/2023